Elastomer Infusion Pump Market Report by Product (Continuous Rate Pumps, Variable Rate Pumps), Application (Pain Management, Infection Management, Chemotherapy, and Others), End User (Hospitals and Clinics, Ambulatory Care, and Others), and Region 2025-2033

Elastomer Infusion Pump Market Report by Product (Continuous Rate Pumps, Variable Rate Pumps), Application (Pain Management, Infection Management, Chemotherapy, and Others), End User (Hospitals and Clinics, Ambulatory Care, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A4289

Market Overview:

The global elastomer infusion pump market size reached USD 1.23 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.32 Billion by 2033, exhibiting a growth rate (CAGR) of 7.3% during 2025-2033.

Report Attribute
 Key Statistics
Base Year
2024
Forecast Years
2025-2033
Historical Years
2019-2024
Market Size in 2024 USD 1.23 Billion
Market Forecast in 2033 USD 2.32 Billion
Market Growth Rate (2025-2033) 7.3%


Elastomer infusion pumps are medical devices used to administer liquid drugs, such as chemotherapy, antibiotics, fluorouracil (5FU), analgesics, and anesthetics, intravenously depending on the therapy required. They contain balloon-like chambers that exert pressure to deliver drugs safely at a steady rate. Nowadays, elastomer infusion pumps that are disposable, compact, portable, and lightweight are widely available for residential purposes. Moreover, several manufacturers are offering products with high flow rate accuracy, minimal residual volume for complete drug administration, and an inline filter to reduce the risk of air embolism and particle contamination.

Elastomer Infusion Pump Market Trends:

A rise in the prevalence of cancer on account of sedentary lifestyles, growing air pollution, and the increasing number of individuals who consume alcohol and smoke tobacco is resulting in the significant need for chemotherapy. This represents one of the primary factors impelling the market growth. In addition, as cellular repair is less effective in older individuals, the risk of developing cancer rises considerably with age. Consequently, the increasing geriatric population is acting as another significant growth-inducing factor. The use of disposable, single-infusion elastomeric pumps also reduces the risk of cross-contamination between patients and healthcare professionals. Moreover, the escalating number of orthopedic procedures and surgeries is influencing the need for elastomer infusion pumps for post-operative pain management. Furthermore, the increasing burden on hospitals, in confluence with shifting preferences towards home-based care, is stimulating the market for elastomer infusion pumps over conventional electric pumps worldwide.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global elastomer infusion pump market report, along with forecasts at the global, regional and country level from 2025-2033. Our report has categorized the market based on product, application and end user.

Breakup by Product:

  • Continuous Rate Pumps
  • Variable Rate Pumps
     

Breakup by Application:

  • Pain Management
  • Infection Management
  • Chemotherapy
  • Others
     

Breakup by End User:

  • Hospitals and Clinics
  • Ambulatory Care
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Avanos Medical Inc., B. Braun Melsungen AG, Baxter International Inc., Daiken Medical Co. Ltd., Nipro Corporation, O&M Halyard Inc, Palex Medical S.A., Pfizer Inc. (Hospira Inc.), pfm medical ag., Samtronic Industria e Comercio LTDA, Smiths Group plc. and Woo Young Medical Co. Ltd.

Report Coverage:

Report Features Details
Base Year of the Analysis 2024
Historical Period 2019-2024
Forecast Period 2025-2033
Units Billion USD
Segment Coverage Product, Application, End User, Region
Region Covered Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Avanos Medical Inc., B. Braun Melsungen AG, Baxter International Inc., Daiken Medical Co. Ltd., Nipro Corporation, O&M Halyard Inc, Palex Medical S.A., Pfizer Inc. (Hospira Inc.), pfm medical ag., Samtronic Industria e Comercio LTDA, Smiths Group plc. and Woo Young Medical Co. Ltd.
Customization Scope 10% Free Customization
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report

The global elastomer infusion pump market was valued at USD 1.23 Billion in 2024.

We expect the global elastomer infusion pump market to exhibit a CAGR of 7.3% during 2025-2033.

The rising prevalence of cancer, along with the introduction of disposable, single-infusion elastomeric pumps that reduces the risk of cross-contamination between patients and healthcare professionals, is primarily driving the global elastomer infusion pump market.

The sudden outbreak of the COVID-19 pandemic has led to the increasing consumer inclination towards home-based patient care, owing to the escalating rate of hospital admissions, which in turn, is positively impacting the global market for elastomer infusion pumps.

Based on the product, the global elastomer infusion pump market can be divided into continuous rate pumps and variable rate pumps. Currently, continuous rate pumps hold the largest market share.

Based on the application, the global elastomer infusion pump market has been categorized into pain management, infection management, chemotherapy, and others. Among these, pain management currently accounts for the majority of the global market share.

Based on the end user, the global elastomer infusion pump market can be bifurcated into hospitals and clinics, ambulatory care, and others. Currently, hospitals and clinics exhibit a clear dominance in the market.

On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global elastomer infusion pump market include Avanos Medical Inc., B. Braun Melsungen AG, Baxter International Inc., Daiken Medical Co. Ltd., Nipro Corporation, O&M Halyard Inc, Palex Medical S.A., Pfizer Inc. (Hospira Inc.), pfm medical ag., Samtronic Industria e Comercio LTDA, Smiths Group plc., and Woo Young Medical Co. Ltd.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Elastomer Infusion Pump Market Report by Product (Continuous Rate Pumps, Variable Rate Pumps), Application (Pain Management, Infection Management, Chemotherapy, and Others), End User (Hospitals and Clinics, Ambulatory Care, and Others), and Region 2025-2033
Purchase Options Discount
Offer
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials